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Although numerous hypotheses, reviewed here, have been proposed the functional role of viral tRNA-like 
structures remains unknown. We describe and discuss a new model based on observations made mainly 
on TYMV RNA. By interacting with the tRNA-like structure, valyl-tRNA synthetase would allow an effi- 
cient translation of the viral genome. The generalization for other viral RNAs is proposed. 
tRNA-like structure Aminoacyl-tRNA synthetase Translation Turnip yellow mosaic virus 
1. INTRODUCTION 
The existence of a tRNA-like structure at the 
3’-end of turnip yellow mosaic virus (TYMV) RNA 
was demonstrated in 1970 by Pinck et al. [l] and 
Yot et al. [2] and has been extended since then to 
many other viral plant RNAs [3] and to a few 
animal viral RNAs [4,5]. The tRNA character is 
mainly shown by the ability of the high-molecular- 
mass viral RNAs to be aminoacylated specifically 
by an aminoacyl-tRNA synthetase. For example, 
TYMV RNAs can be esterfied with valine and 
bromovirus RNAs with tyrosine in the presence of 
the corresponding aminoacyl-tRNA synthetase. 
Interestingly enough, for the two TYMV RNAs 
(MI = 2 OOO 000 and 260 000) it has been shown (i) 
that the valylation reaction occurs with similar 
kinetic constants to those found for the aminoacy- 
lation of canonical tRNAVa’ (Mr = 25 000) [6] and 
(ii) that the isolated 3’-fragment of the RNAs 
(n = 159) behaves identically to the intact viral 
RNA in the presence of the synthetase [7]. Besides 
interacting with aminoacyl-tRNA synthetases, these 
viral RNAs are also recognized by several other 
tRNA speific proteins, i.e., nucleotidyl-tRNA 
transferase [2,8], elongation factor EF-Tu and 
EF-1 [9,10]. 
semblance at the level of secondary structure with 
the classical cloverleaf model of tRNAs, it was 
possible to propose three-dimensional models 
bearing some features of the L-shaped conforma- 
tion of tRNA [13,14]. However, despite the impor- 
tant progress made recently in understanding the 
conformation of tRNA-like molecules, we still do 
not understand the functional necessity of these 
structures during the viral cycle. 
2. PREVIOUSLY PROPOSED FUNCTIONS 
FOR VIRAL tRNA-LIKE STRUCTURES 
Recently, the secondary structure of several 
tRNA-like 3’-ends have been determined experi- 
mentally [7,11,12]. Although they show poor re- 
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Since their discovery, numerous functional pos- 
sibilities have been proposed for viral tRNA-like 
structures (reviews [3,15,16]). Considering the 
involvement of tRNA-like structures in viral infec- 
tivity [3] and their potentiality to be efficiently 
aminoacylated in vitro [6] and in vivo [ 17-191, as 
well as to interact with several factors of the pro- 
tein synthesis machinery, an obvious role would be 
the classical amino acid donor function in ribo- 
some-dependent protein synthesis. This is not the 
case [3,16,20] as evidenced, for example, by nega- 
tive protein synthesis assays conducted with puri- 
fied tyrosylated 3’-fragments of brome mosaic 
virus RNAs [3] or with eggplant mosaic virus RNA 
[20]. This behaviour is in fact understandable 
because it seems unlikely that tRNA-like structures 
exhibiting various sizes [ 13,141, and consequently 
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various overall tertiary conformations compared 
with classical tRNAs, could easily be accommo- 
dated in the ribosomal A and P sites. In agreement 
with this view is the absence in TYMV RNA of 
structural features found in the D-and-T+ loops of 
elongator tRNAs [7]. Another reason is the weak 
binding of GTP in the ternary complex formed by 
elongation factor, GTP and aminoacyl-RNA [lo] 
which would not allow an efficient positioning of 
charged viral RNA on ribosome. 
Interaction of viral RNA with elongation factors 
has led several authors (e.g., [9,10]) to propose 
that tRNA-like structures are involved in viral 
RNA replication. In fact, the QB replicase includes 
the prokaryotic elongation factors EF-Tu and EF- 
Ts as subunits [21]. Thus by analogy, it was pro- 
posed that tRNA-like structures interacting with 
plant replicase could be active initiation sites for 
viral replication, provided these enzymes would 
contain an elongation factor as subunit, or more 
generally structural features of elongation factors. 
However, no experimental data have been reported 
to support this hypothesis. 
The involvement of tRNA-like structures in 
some non-classical tRNA function cannot be elimi- 
nated. For example, there are structural analogies 
between the TYMV RNA 3’-end and Staphylo- 
coccus epidermidis tRNAGly which is involved in 
ribosome-independent cell wall protein synthesis 
[7,22]. As with tRNAs priming oncornavirus re- 
verse transcription 1231, the viral tRNA-like struc- 
tures could act as a primer in viral replication. 
Although the very attractive hypotheses pro- 
posed so far cover numerous possibilities and are 
not mutually exclusive, it seems to us likely that the 
easiness with which tRNA-like structures are 
aminoacylated, or in a more general way their 
capacity to interact with aminoacyl-tRNA synthe- 
tases, has to be related to their putative biological 
function. 
3. POSSIBLE INVOLVEMENT OF THE tRNA- 
LIKE STRUCTURE IN TYMV GENOMIC 
RNA TRANSLATION 
We propose here an alternative biological func- 
tion for the tRNA-like structure of TYMV, in 
agreement with the general frame recently proposed 
by Ames et al. [24] according to which structural 
features of tRNA can act as regulatory signals in 
genetic expression. The model which will be dis- 
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cussed here is based on the following observations: 
(i) TYMV genomic RNA (Mr = 2 000000) can 
exist in a circular form as first evidenced by light 
scattering measurements [25]. This was later sub- 
stantiated by the observation of base complemen- 
tarities between the 3’- and S-end of the viral RNA 
[26]. In a systematic search we could compute 
several possible base-pairing schemes with stretches 
of 6 or more continuous base-pairs. The existence 
of a circular form is strengthened by the similar 
energies in double-stranded regions in the closed 
RNA and the folded tRNA-like structure (fig. 1,2); 
(ii) all base-pairing schemes present the same 
structural features, namely a disruption of the 
secondary structure of the free 3’-end of the RNA 
except for the anticodon arm; 
(iii) the potential initiation codon located at the 
S-end of the RNA [26,28] is base-paired with a 
complementary sequence present in the tRNA-like 
structure (see fig. 1A) suggesting that circular RNA 
is untranslatable. 
In our model, summarized in fig.2, the tRNA- 
like structure present at the 3’-end of the viral 
RNA would be, via interaction with cellular valyl- 
tRNA synthetase, an enhancer of viral RNA trans- 
lation. 
Inside the infected cell the two forms of genomic 
TYMV RNA might exist in an equilibrium governed 
by intracellular local conditions. Valyl-tRNA syn- 
thetase, interacting either with the open or the cir- 
cular RNA would shift this equilibrium toward the 
linear form in which the initiation codon AUG is 
accessible so that translation of the viral RNA is 
favoured. Interaction of valyl-tRNA synthetase 
with the structured tRNA-like end would maintain 
the linear form of TYMV RNA. Interaction of the 
synthetase with the circular form implies that 
recognition with the remaining anticodon stem is 
possible. Our recent studies on the interaction 
domain of yeast valyl-tRNA synthetase and the 
tRNA-like fragment support this last proposal. 
Experiments based on the accessibility of the 
RNA to ribonucleases or chemicals show that the 
most important interaction sites with valyl-tkNA 
synthetase occur in the anticodon stem of the 
tRNA-like structure (to be published). These do- 
mains (inset of fig.2) are identical with those found 
in yeast tRNAVa’ when it interacts with its cognate 
aminoacyl-tRNA synthetase [29,30]. It is inter- 
esting to note that the anticodon stem and loop 
region of tRNA is involved in interaction with 
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Fig.1. Probable base-pairings between the S- and f’-end of several plant viral RNAs. Sequence data are from 
[~,36,37,39,48,50,51]. (A) Turnip yeBow mosaic virus genomic RNA [26&S]; (B) tobacco mosaic virus genomic RNA 
1491; (C) satelite tobacco necrosis virus RNA [39]; (D) alfalfa mosaic virus RNA1 [SO]; (FQ alfalfa mosaic virus RNA2 
[Sl]; (P) cucumber mosaic virus RNA3 [37]; (G) brome mosaic virus RNA3 [36]. The proposed models were computed 
from diagonal plots and the free energies calculated according to Salser [47]. The potential initiation codons AU0 are 
underlined and pointed. 
aminoacyl-tRNA synthetase in many tRNA/syn- 
thetase systems (e.g., 129,321). An ‘unwinding’ 
property of valyl-tRNA synthetase can be 
understood if one assumes that the first event in 
that process would involve a recognition with 
limited structural features of the ERNA-like struc- 
ture, i.e., the anticodon stem region in the TYMV 
system. Partial recognition might be possible since 
it is generally accepted that tRNA-aminoacyl- 
tRNA synthetase recognition does not require all 
potential interaction sites on tRNA [33]. 
TYMV possesses a subgenomic RNA bearing at 
its 3’-terminus the same tRNA-like structure. Thus, 
the possibility exists of duplex formation between 
the 5’-end of genomic RNA and the 3’-end of 
subgenomic RNA f26]. Here also interaction with 
valyl-tRNA synthetase could disrupt or prevent 
such complexes by a similar mechanism. 
It could be suggested that competition of valyl- 
tRNA synthetase with endogenous tRNAs could 
prevent an efficient interaction with TYMV RNA. 
This possibility can be rejected since (i) the intra- 
cellular concentrations of aminoacyl-tRNA syn- 
thetases are high; they were shown to be in the 
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Fig.2. Model of alternative conformations of TYMV RNA involved in genome translation. The amount of open and 
closed forms, in which the active initiation codon AUG is free or buried, is shifted toward the open conformation by 
valyl-tRNA synthetase interacting with features of the tRNA-like structure. The sequence and the secondary structure 
of the 3’-terminal tRNA-like fragment 171 is given in the inset. Energies of the stems cafculated according to 1471 are 
given; heavy lines indicate contact points with v~yl-tRNA synthetase. Loop 3 corresponds to the anticodon loop also 
schematised in the circular form of viral RNA. 
sly Val Rs Val RS 
micromolar range in several organisms (e.g., [34]) 
and (ii) all cellular aminoacyl-tRNA synthetases 
are not necessarily complexed with tRNA since 
charged tRNA molecules will be carried by elonga- 
tion factors also present at high levels (e.g., [35]). 
4. GE~~LI~T~GN: ~GULATGRY FUNC- 
TIONS FOR tRNA-LIKE STRUCTURES 
The model discussed for TYMV can be extended 
to other RNA viruses. As seen in fig.lB-G, ener- 
getically favourable circular models can be pro- 
posed for many viral RNAs. Similarly to TYMV 
RNA, 5’/3’ interactions between genomic and sub- 
genomic RNA species might exist. In all cases the 
initiation codon AUG is buried in a higher order 
structure which makes such structures ineffective 
in translation. As will be discussed below, by inter- 
acting with tRNA-like structural features, arnino- 
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acyl-tRNA syuthetase or other proteins, could 
promote the translation of those RNAs. 
Concerning brome mosaic and cucumber mosaic 
viral RNAs, both aminoacylatable with tyrosine, 
circular forms with buried initiation codons were 
proposed 136,371. The base-pairing between the 
two ends of the RNAs (fig.lF,G), however, is dif- 
ferent from that of TYMV, so that no apparent 
structural domains of tRNA 11 l] capable of being 
recognized by the synthetase remain. Although it 
cannot be excluded that tyrosyl-tRNA synthetase 
could unwind such a structure, it seems more 
plausible that the synthetase could unwind such a 
structure, it seems more plausible that the synthe- 
tase acts as an inhibitor of circularization by inter- 
acting with the tRNA-like structure present at the 
3’-end of linear RNA. This can also hold true for 
tobacco mosaic virus RNA (aminoacylatabIe by 
histidine) [38] and satellite tobacco necrosis virus 
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RNA (assumed to be aminoacylated by methio- 
nine) [39]. Both RNAs have a 3’-end which can be 
folded into a secondary structure model similar to 
that of TYMV [7,40] and strong base complemen- 
tarities are present between their S- and 3’-ends 
(fig.lB,C). 
The question about the biological significance of 
S/3 complementarities in viral RNAs might be 
raised. Gould and Symons [37] suggested that in- 
teraction between the S-end of cucumber mosaic 
virus RNA3 and the 3’-end of RN& would permit 
the coencapsidation of these two RNAs. One can 
also imagine that circularization of the high-mole- 
cular-mass RNA would allow a tight packaging 
inside the viral capsid. Similarly to messenger 
RNAs the TYMV RNA is highly susceptible to de- 
gradation [41], a property clearly evidenced for the 
tRNA-like 3’-end [7]; higher-order structure of the 
RNA would stabilize the molecule and enzymatic 
reparation of nicked RNA could even be facilitated 
in double-stranded regions. 
In the framework of our model, the aminoacyla- 
tion of the tRNA-like structure is not a necessary 
prerequisite for the function of these molecules. 
We note the quasi-absence of 3’-terminal adeno- 
sine in TYMV RNA [6]. Thus, this RNA is only 
valylatable after reconstitution with nucleotidyl- 
tRNA transferase [2]. Aminoacylation, however, 
might indirectly enhance the efficiency of the 
translation process. Indeed elongation factors 
interacting with charged viral RNA [9,10] could 
act as relay molecules for the synthetase in main- 
taining RNA in a translatable form, thus leaving 
the level of free synthetase high. On the other 
hand, some viral RNAs have been shown not to be 
aminoacylatable at all (review, [3,16]). However, 
the possibility cannot be excluded that these RNAs 
possess tructural features able to exercise transla- 
tional control, via interaction with aminoacyl- 
tRNA synthetases which does not involve the cata- 
lytic function of the enzyme. This could be the 
consequence, as already pointed out by Hall [3], of 
“the evolution of tRNA-like sequences towards 
structures gradually loosing the aminoacylating 
potentiality”. Alternatively, other tRNA specific 
proteins recognizing the 3’-end of viral RNAs might 
play a similar role in translation as the synthetase. 
We note that coat protein from alfalfa mosaic virus 
can bind strongly to the 3’-ends of the viral RNAs 
[42]; interestingly enough these RNAs possess 
strong S/3’ base complementarities (fig. lD,E). 
In this context it is worth mentioning the recent 
proposal made by Ames and his colleagues [24] on 
the regulatory implications of a tRNA-like struc- 
ture present in the leader mRNA of the histidine 
attenuator region in Salmonella typhimurium. 
This structure shows high sequence homologies 
with tRNAm”, especially for the anticodon and 
T$-stem and loop regions. As discussed by these 
authors any protein interacting with tRNAHiS (i.e., 
tRNA-modifying enzymes, aminoacyl-tRNA syn- 
thetases) might be able to interact with features of 
the tRNA-like structure. This could influence 
attenuator loop formation or mRNA stability, 
thus modulating transcription or translation or 
both [24]. The observation made for the histidine 
operon is not unique. In the gfyS gene from 
Escherichia coli a 15-nucleotide long sequence was 
found similar to that in the anticodon region of 
tRNAGry [43]. Furthermore a tRNA-like structure 
was described inside the thrS gene of E. coli [44]. 
For that example the hypothesis was put forward 
that threonyl-tRNA synthetase interacting with 
this cloverleaf would block translation of the syn- 
thetase mRNA [44]. Following these lines one 
could rationalize the presence of some unexpected 
tRNA-like structures assumed to be internally 
located in viral genomes (i.e., [4,5,45,46]). 
Taking all these observations together one might 
wonder whether structures bearing conformational 
features of tRNAs do not represent a general class 
of signals designed by nature to regulate genome 
expression at the translational evel. The fact that 
tRNA-like structures were first discovered in viral 
RNAs is understandable since these RNAs are sim- 
plified genomes in which such structures could 
early be experimentaly detected thanks to their 
aminoacylation ability. 
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